| Literature DB >> 30090815 |
Alireza Najafpour1, Houman Azizizadeh1.
Abstract
OBJECTIVE: To investigate effects of intraperitoneally administration of α-tocopherol loaded nanoparticles (TNP) on ischemia-reperfusion injury in ovaries.Entities:
Keywords: Intraperitoneal; Ischemia-reperfusion; Ovary; α-tocopherol nanoparticles
Year: 2018 PMID: 30090815 PMCID: PMC6078481 DOI: 10.29252/beat-060304
Source DB: PubMed Journal: Bull Emerg Trauma ISSN: 2322-2522
Fig. 1Histologic micrographs of the ovarian tissue in SHAM (A), I (B), I/R (C), I/T(D), I/R/T (E), I/TNP (F) and I/R/TNP (G) groups. (A) Shows normal secondary follicles with compact stroma between them. (B) Many follicles at different stages of development are observed. Edematous ovarian stroma and multiple dilated congested blood vessels with some areas of hemorrhage are shown. (C) Ovarian follicles at different stages of development with edema in the stroma and hemorrhage are observed. (D) Many follicles at different stages of development are seen. There is edematous ovarian stroma and multiple dilated congested blood vessels with some areas of haemorrhage. (E) Preserved follicles at different stages of development with the presence of mild edema, congested blood vessels, and hemorrhage are seen. (F) Shows persistent marked edema among follicles at different stages of development. (G) Normally appearing ovarian tissue with preserved healthy follicles at different stages of development with slight edema or hemorrhage is observed.
Comparison of the activities of SOD, NOS, MDA, MPO, GSH, GPO, GSHRd, GST and a DNA damage product of 8-OHGua/Gua in the ovarian tissues of the animals of the all experimental groups. Data are expressed as Mean ± SD.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
| 69.1 ± 0.53 | 35.3 ± 0.27 | 57.6 ± 0.24 | 53.9 ± 0.34 | 73.8 ± 0.29 | 61.7 ± 0.45 | 78.9 ± 0.37 |
|
| 3.9 ± 0.15 | 3.7 ± 0.12 | 3.6 ± 0.50 | 3.3 ± 0.17 | 3.3 ± 0.21 | 3.4 ± 0.15 | 3.2 ± 0.17 |
|
| 5.8 ± 0.15 | 12.6 ± 0.20 | 11.3 ± 0.21 | 9.5 ± 0.31 | 6.9 ± 17 | 8.5 ± 0.66 | 5.3 ± 18 |
|
| 6.6 ± 0.12 | 16.5 ± 0.45 | 13.8 ± 0.24 | 12.5 ± 0.23 | 8.9 ± 0.49 | 10.4 ± 0.15 | 7.2 ± 0.38 |
|
| 9.7 ± 0.34 | 2.8 ± 0.25 | 4.8 ± 0.32 | 5.4 ± 0.10 | 7.1 ± 0.17 | 6.3 ± 0.21 | 8.3 ± 0.14 |
|
| 38.4 ± 2.63 | 12.9 ± 2.41 | 17.3 ± 1.45 | 20.3 ± 1.57 | 29.4 ± 2.55 | 22.5 ± 1.33 | 3.27 ± 2.69 |
|
| 33.6 ± 2.25 | 9.3 ± 1.85 | 16.7 ± 1.24 | 19.8 ± 1.85 | 24.2 ± 2.33 | 21.5 ± 1.15 | 28.6 ± 2.55 |
|
| 21.7 ± 1.23 | 10.5 ± 1.24 | 14.8 ± 1.35 | 16.3 ± 1.24 | 19.5 ± 1.12 | 17.6 ± 1.07 | 20.3± 1.24 |
|
| 1.2 ± 0.15 | 2.6 ± 0.12 | 2.2± 0.18 | 1.6 ± 0.17 | 1.6 ± 0.14 | 1.6 ± 0.10 | 1.3 ± 0.17 |
I: Ischemia;
I/R: Ischemia-reperfusion;
I/T: Ischemia plus interaperitoneal administration of α-tocopherol;
I/R/T: Ischemia plus reperfusion plus interaperitoneal administration of α-tocopherol;
I/TNP: Ischemia plus intraperitoneal administration of α-tocopherol loaded nanoparticles;
I/R/TNP: Ischemia plus reperfusion plus intraperitoneal administration of α-tocopherol loaded nanoparticles;
SOD: Superoxide dismutase;
NOS: Nitric oxide synthase;
MDA: Malondialdehyde;
MPO: Myeloperoxidase;
tGSH: Total glutathione;
GPO: Glutathione peroxidase;,
GSHRd: Glutathione reductase;
GST: Glutathione S-transferase;
8-OHGua/Gua: 8-hydroxy-2 deoxyguanine;
P<0.0 vs. other experimental groups.